These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14711340)
1. Prospects for vaccine development against Buruli disease. Huygen K Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340 [TBL] [Abstract][Full Text] [Related]
2. Buruli ulcer (Mycobacterium ulcerans infection). Walsh DS; Portaels F; Meyers WM Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836 [TBL] [Abstract][Full Text] [Related]
3. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast]. van der Graaf WT; Scherpbier RW; van der Werf TS Ned Tijdschr Geneeskd; 1999 Feb; 143(6):312-6. PubMed ID: 10221089 [TBL] [Abstract][Full Text] [Related]
4. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Nackers F; Dramaix M; Johnson RC; Zinsou C; Robert A; DE Biurrun Bakedano E; Glynn JR; Portaels F; Tonglet R Am J Trop Med Hyg; 2006 Oct; 75(4):768-74. PubMed ID: 17038709 [TBL] [Abstract][Full Text] [Related]
8. Buruli ulcer: the third most common mycobacterial infection. Weir E CMAJ; 2002 Jun; 166(13):1691. PubMed ID: 12126327 [No Abstract] [Full Text] [Related]
9. Mycobacterium ulcerans infection. van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380 [TBL] [Abstract][Full Text] [Related]
10. [Mycobacterium ulcerans infection]. Dega H; Chosidow O; Barete S; Carbonnelle B; Grosset J; Jarlier V Ann Med Interne (Paris); 2000 Sep; 151(5):339-44. PubMed ID: 11033467 [TBL] [Abstract][Full Text] [Related]
12. Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Renzaho AM; Woods PV; Ackumey MM; Harvey SK; Kotin J Trop Med Int Health; 2007 Mar; 12(3):445-58. PubMed ID: 17313516 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form. Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971 [TBL] [Abstract][Full Text] [Related]
16. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice. Tanghe A; Adnet PY; Gartner T; Huygen K Infect Immun; 2007 May; 75(5):2642-4. PubMed ID: 17325046 [TBL] [Abstract][Full Text] [Related]
17. WHO joins battle against a new emerging disease, Buruli ulcer. Indian Pediatr; 1998 Jun; 35(6):581. PubMed ID: 10216666 [No Abstract] [Full Text] [Related]
18. [Epidemiologicl aspects of Buruli ulcer in Côte d'Ivoire: results of a national survey]. Kanga JM; Kacou ED Bull Soc Pathol Exot; 2001 Mar; 94(1):46-51. PubMed ID: 11346983 [TBL] [Abstract][Full Text] [Related]
19. Buruli ulcer disease in Cameroon rediscovered. Noeske J; Kuaban C; Rondini S; Sorlin P; Ciaffi L; Mbuagbaw J; Portaels F; Pluschke G Am J Trop Med Hyg; 2004 May; 70(5):520-6. PubMed ID: 15155984 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Tanghe A; Content J; Van Vooren JP; Portaels F; Huygen K Infect Immun; 2001 Sep; 69(9):5403-11. PubMed ID: 11500410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]